A German Pharmaceutical opportunity
Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility and endocrinology. We divide our report in 3 sectors:
- Ratio summary
- Peer group confrontation
- Next 90/180 days share price movement forecasting using our proprietary “Evidence Based Performance Analysisâ€Â© approach​
Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The company's segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.
Since 2003, Ambrosetti Asset Management is a stockbroking company authorized by Governmental Authorities to execute advisory services for investment and wealth management. We are specialized in providing support services to asset management activities (asset selection, asset allocation, market timing, analysis & research) as well as tailor-made solutions and strategies.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.